- Home
- NVRO vs AMRN Comparison
NVRO vs AMRN Comparison
Compare NVRO & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRO
- AMRN
- Stock Information
- Founded
- NVRO 2006
- AMRN 1989
- Country
- NVRO United States
- AMRN Ireland
- Employees
- NVRO N/A
- AMRN N/A
- Industry
- NVRO Medical/Dental Instruments
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- NVRO Health Care
- AMRN Health Care
- Exchange
- NVRO Nasdaq
- AMRN Nasdaq
- Market Cap
- NVRO 221.2M
- AMRN 189.2M
- IPO Year
- NVRO 2014
- AMRN 1993
- Fundamental
- Price
- NVRO $5.85
- AMRN $0.44
- Analyst Decision
- NVRO Hold
- AMRN Buy
- Analyst Count
- NVRO 12
- AMRN 1
- Target Price
- NVRO $7.24
- AMRN N/A
- AVG Volume (30 Days)
- NVRO 1.3M
- AMRN 2.1M
- Earning Date
- NVRO 03-04-2025
- AMRN 03-12-2025
- Dividend Yield
- NVRO N/A
- AMRN N/A
- EPS Growth
- NVRO N/A
- AMRN N/A
- EPS
- NVRO N/A
- AMRN N/A
- Revenue
- NVRO $408,518,000.00
- AMRN $228,614,000.00
- Revenue This Year
- NVRO $1.55
- AMRN N/A
- Revenue Next Year
- NVRO $4.36
- AMRN $19.11
- P/E Ratio
- NVRO N/A
- AMRN N/A
- Revenue Growth
- NVRO N/A
- AMRN N/A
- 52 Week Low
- NVRO $3.17
- AMRN $0.35
- 52 Week High
- NVRO $13.84
- AMRN $1.11
- Technical
- Relative Strength Index (RSI)
- NVRO 70.38
- AMRN 40.65
- Support Level
- NVRO $5.83
- AMRN $0.42
- Resistance Level
- NVRO $5.81
- AMRN $0.50
- Average True Range (ATR)
- NVRO 0.02
- AMRN 0.03
- MACD
- NVRO -0.02
- AMRN 0.00
- Stochastic Oscillator
- NVRO 95.00
- AMRN 47.27
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.